Cargando…
Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains
For newly diagnosed breast cancer, estrogen receptor status (ERS) is a key molecular marker used for prognosis and treatment decisions. During clinical management, ERS is determined by pathologists from immunohistochemistry (IHC) staining of biopsied tissue for the targeted receptor, which highlight...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670411/ https://www.ncbi.nlm.nih.gov/pubmed/33199723 http://dx.doi.org/10.1038/s41467-020-19334-3 |